TITLE

An oncologist turned HIV expert takes on another role

AUTHOR(S)
Volberding, Paul A.
PUB. DATE
September 2011
SOURCE
Infectious Disease News;Sep2011, Vol. 24 Issue 9, p4
SOURCE TYPE
Newspaper
DOC. TYPE
Editorial
ABSTRACT
The author explains how proud he is as an oncologist and a human immunodeficiency syndrome (HIV) expert to have accepted the offer to become the chief medical editor of the journal "Infectious Disease News."
ACCESSION #
66935769

 

Related Articles

  • Type II Oncologists. Vachon, Mary // Journal of Palliative Medicine;Jan2009, Vol. 12 Issue 1, p9 

    A letter to the editor is presented about the type I and type II oncologists that appear on the editorial section of "Journal of Palliative Medicine" that describes a woman who had advanced cervical cancer in the U.S.

  • Russian Scientist Denied Exit Visa, Seeks Help. Kazis, Lewis E.; Irlin, Iosef S. // American Journal of Public Health;May84, Vol. 74 Issue 5, p519 

    A letter to the editor is presented regarding the refusal by the Russian government to approve the exit visa application of an Israeli oncologist.

  • FROM OUR READERS.  // Hem/Onc Today;11/25/2009, Vol. 10 Issue 22, p42 

    A letter to the editor in response to the article "Damage Control: The Industry is Bracing for an Oncologist Shortage," published in the May 10, 2009 issue, is presented.

  • Oncologists and End-of-Life Care. Saraiya, Biren // Journal of Palliative Medicine;Feb2009, Vol. 12 Issue 2, p116 

    A letter to the editor is presented which discusses how the oncologist meet the needs of their patients from the day of diagnosis to the end-of-life care delivery.

  • Putting 'retired' oncologists to work in the workforce shortage. Cohen, James M. // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p6 

    A letter to the editor is presented in response to an article about the impending shortage of oncologists published in the May 10, 2009 issue.

  • Does U.S. lag behind Europe in organ-conserving cancer... Reynolds, Tom // JNCI: Journal of the National Cancer Institute;12/6/95, Vol. 87 Issue 23, p1736 

    Compares cautious, conservative European oncologists to their aggressive, gung-ho American counterparts. Instances when being conservative can be progressive; Information from the 8th European Cancer Conference in Paris; Answers vary according to particular disease and treatment; Regional...

  • Non-physician providers may ease oncology work force crisis. Eastman, Peggy // JNCI: Journal of the National Cancer Institute;04/15/98, Vol. 90 Issue 8, p567 

    Suggests that over the next ten years following 1998, non-physician providers may be used to ease the oncology work force in the United States. Reason for this suggestion; Example of non-physician providers; Views of James L. Wade III, M.D., president of the Association of Community Cancer...

  • Novocure's systems used at oncology hospitals.  // Medical Device Daily;12/5/2011, Vol. 15 Issue 231, p10 

    The article focuses on neuro-oncologists and hospitals in the U.S. that have selected the NovoTTF-100A System, a device for treating recurrent glioblastoma multiforme that is made by Portsmouth, New Hampshire-based Novocure.

  • Legal problems for oncologists facing hematologic disorders: an increasing dilemma. Jacob, Jarry S. // Hem/Onc Today;8/10/2009, Vol. 10 Issue 15, p4 

    The author reflects on legal problems facing oncologists on issues involving hematologic disorders.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics